Yoshioka A - Search Results

1

Excision of pseudotumour in a patient with haemophilia A and inhibitor managed with recombinant factor VIIa.

Takedani H, Mikami S, Kawasaki N, Abe Y, Arai M, Naka H, Yoshioka A. Takedani H, et al. Among authors: yoshioka a. Haemophilia. 2004 Mar;10(2):179-82. doi: 10.1111/j.1365-2516.2004.00784.x. Haemophilia. 2004. PMID: 14962208

2

Clinical conditions and risk factors for inhibitor-development in patients with haemophilia: A decade-long prospective cohort study in Japan, J-HIS2 (Japan Hemophilia Inhibitor Study 2).

Nogami K, Taki M, Matsushita T, Kojima T, Oka T, Ohga S, Kawakami K, Sakai M, Suzuki T, Higasa S, Horikoshi Y, Shinozawa K, Tamura S, Yada K, Imaizumi M, Ohtsuka Y, Iwasaki F, Kobayashi M, Takamatsu J, Takedani H, Nakadate H, Matsuo Y, Matsumoto T, Fujii T, Fukutake K, Shirahata A, Yoshioka A, Shima M; J-HIS2 study group. Nogami K, et al. Among authors: yoshioka a. Haemophilia. 2022 Sep;28(5):745-759. doi: 10.1111/hae.14602. Epub 2022 Jun 11. Haemophilia. 2022. PMID: 35689832

3

Surgery for a chronic cystic hematoma on the right thigh in a hemophiliac A with a potent factor VIII inhibitor.

Masuhara K, Shimizu T, Kawasaki N, Fukui H, Sakai Y, Shima M, Mikami S, Yoshioka A. Masuhara K, et al. Among authors: yoshioka a. Nihon Seikeigeka Gakkai Zasshi. 1982 Dec;56(12):1719-27. Nihon Seikeigeka Gakkai Zasshi. 1982. PMID: 6820658

4

Clinical trial to investigate the pharmacokinetics, pharmacodynamics, safety, and efficacy of recombinant factor VIIa in Japanese patients with hemophilia with inhibitors.

Shirahata A, Kamiya T, Takamatsu J, Kojima T, Fukutake K, Arai M, Hanabusa H, Tagami H, Yoshioka A, Shima GM, Naka GH, Fujita GS, Minamoto Y, Kamizono J, Saito H. Shirahata A, et al. Among authors: yoshioka a. Int J Hematol. 2001 Jun;73(4):517-25. doi: 10.1007/BF02994016. Int J Hematol. 2001. PMID: 11503968 Clinical Trial.

5

Unresponsiveness to factor VIII inhibitor bypassing agents during haemostatic treatment for life-threatening massive bleeding in a patient with haemophilia A and a high responding inhibitor.

Hayashi T, Tanaka I, Shima M, Yoshida K, Fukuda K, Sakurai Y, Matsumoto T, Giddings JC, Yoshioka A. Hayashi T, et al. Among authors: yoshioka a. Haemophilia. 2004 Jul;10(4):397-400. doi: 10.1111/j.1365-2516.2004.00924.x. Haemophilia. 2004. PMID: 15230956

6

Perioperative safety and hemostatic efficacy of Advate^® in patients with hemophilia A in a postmarketing surveillance in Japan.

Nogami K, Takedani H, Shima M, Yoshioka A, Matsushita T, Takamatsu J, Taki M, Fukutake K, Uchikawa H, Takagi H, Arai M, Engl W, Shirahata A. Nogami K, et al. Among authors: yoshioka a. Int J Hematol. 2018 Jul;108(1):22-29. doi: 10.1007/s12185-018-2434-2. Epub 2018 Mar 28. Int J Hematol. 2018. PMID: 29594923 Clinical Trial.

7

Laboratory evidence of DIC under FEIBA treatment of a hemophilic patient with intracranial bleeding and high titre factor VIII inhibitor.

Fukui H, Fujimura Y, Takahashi Y, Mikami S, Yoshioka A. Fukui H, et al. Among authors: yoshioka a. Thromb Res. 1981 Apr 1-15;22(1-2):177-84. doi: 10.1016/0049-3848(81)90319-4. Thromb Res. 1981. PMID: 6794176 No abstract available.

8

An analysis of factors affecting the incidence of inhibitor formation in patients with congenital haemophilia in Japan.

Shirahata A, Fukutake K, Higasa S, Mimaya J, Oka T, Shima M, Takamatsu J, Taki M, Taneichi M, Yoshioka A; STUDY GROUP ON FACTORS INVOLVED IN FORMATION OF INHIBITORS TO FACTOR VIII AND IX PREPARATIONS. Shirahata A, et al. Among authors: yoshioka a. Haemophilia. 2011 Sep;17(5):771-6. doi: 10.1111/j.1365-2516.2011.02599.x. Epub 2011 Jun 20. Haemophilia. 2011. PMID: 21682824

9

First trimester prenatal diagnosis of haemophilia A using factor VIII gene probe.

Yoshioka A, Naka H, Nishimura T, Kuze K, Tanaka I, Mikami S, Matsumoto M, Yoshioka K, Fukui H. Yoshioka A, et al. Among authors: yoshioka k. Jinrui Idengaku Zasshi. 1989 Jun;34(2):135-41. doi: 10.1007/BF01912482. Jinrui Idengaku Zasshi. 1989. PMID: 2570172

10

Safety and efficacy of a new recombinant FVIII formulated with sucrose (rFVIII-FS) in patients with haemophilia A: a long-term, multicentre clinical study in Japan.

Yoshioka A, Shima M, Fukutake K, Takamatsu J, Shirahata A; Coganate FS Study Group. Yoshioka A, et al. Haemophilia. 2001 May;7(3):242-9. doi: 10.1046/j.1365-2516.2001.00511.x. Haemophilia. 2001. PMID: 11380627 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

636 results

Search Page

Filters